car-t crispr cas9

With the aid of superior technologies and skillful scientific teams, Creative Biolabs has been a well-known service provider in the field of antibody discovery and immunotherapy. Now, we are proud to present a powerful platform combing Chimeric Antigen Receptor (CAR) T cell therapy with the Clustered, Regularly Interspaced, Short Palindromic Repeats-associated endonuclease 9 (CRISPR/Cas9) technology to our worldwide clients, aiming to push their projects closer to clinical trials.